SipNose-topiramate: a potential novel approach to binge eating management
Abstract Background Binge-eating disorder) BED) is the most common eating disorder in the United-States. Daily, orally administered topiramate has shown BED treatment efficacy, with two major limitations: frequent and severe side effects and slow time-to-effect. SipNose is a novel non-invasive intra...
Bewaard in:
| Hoofdauteurs: | , , , , , , , , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
BMC
2023-06-01
|
| Reeks: | Journal of Eating Disorders |
| Onderwerpen: | |
| Online toegang: | https://doi.org/10.1186/s40337-023-00825-9 |
| Tags: |
Geen labels, Wees de eerste die dit record labelt!
|